CYP2D6
The company is seeing its CYP2C19 test adopted broadly as it prepares to submit a new application to the FDA for an assay targeting neurodegenerative disease.
AMP-led Expert Groups Release Clinical CYP2D6 Pharmacogenomic Testing Recommendation
The consensus guideline offers a two-tier categorization of alleles that are recommended for clinical CYP2D6 pharmacogenetic testing.
University of Chicago Program Aims to Improve Knowledge Transfer for PGx Testing
The program uses an informatics system that converts genotype results to "traffic lights" telling clinicians whether a drug is acceptable for a certain patient.